Healthcare in a Changing Climate 2025
Page 26 of 47 · WEF_Healthcare_in_a_Changing_Climate_2025.pdf
Impact of Orphan Drug Act on rare disease investment in the US FIGURE 5
Source: Rana, P . and Chawla, S.99Orphan product appr oval Orphan pr oduct designationNumber of orphan products
Year0
19831238 6 9 910 11 11 112618 20 20 20 201526 263249 4839
2416 17 15 14 13 13613 13 153949
335771778981
556558 57 57536778 78
6495132
123142
119165 164195203
190260293354
333
701984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
201650100150200250300350400Number of orphan product approvals and designations by FDA (1983-2016)
Complexity of climate-health
data integration
The complexity of climate-health data integration,
which involves integrating climate information into
routine decision-making in the health sector, is
another significant roadblock.
One complication is the diversity of regulations
governing data privacy and security. Rules such
as Europe’s General Data Protection Regulation
(GDPR),104 the US’s Health Insurance Portability and
Accountability Act105 and China’s Personal Information
Protection Law106 impose varying privacy standards.
Although these regulations are an important step in
data security and digital privacy, they make cross-
border data sharing and integration challenging.
Building and investing in advanced climate-health
data platforms107 that integrate diverse data sets
would enable better forecasting108 of climate-driven
diseases, improving response times and leading to more targeted interventions.109 Investment
in AI-driven platforms that link environmental,
biodiversity and health data can help identify
disease patterns influenced by climate change,
enabling pharmaceutical companies to proactively
develop solutions. For instance, the Global Virome
Project,110 which unites climate and health experts
to predict zoonotic disease outbreaks, serves as a
model that could be adapted for climate-sensitive
diseases. With better predictive tools, companies
can design more effective solutions that address
both emerging health risks and longer-term public
health impacts.
In 2023, private and public sector thought
leaders, including WHO, the World Meteorological
Organization, the Wellcome Trust and the
Rockefeller Foundation, agreed on a three-year
action agenda111 to integrate climate and health
data and surveillance systems. This includes
identifying high-priority gaps and initial requirements
for the integration of climate and weather
information into health information systems.
Healthcare in a Changing Climate: Investing in Resilient Solutions
26
Ask AI what this page says about a topic: